Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms

Abstract

 

Introduction: Most conventional drug delivery systems are not acceptable for pediatric patients as they differ in their developmental status and dosing requirements from other subsets of the population. Technology platforms are required to aid the development of age-appropriate medicines to maximize patient acceptability while maintaining safety, efficacy, accessibility and affordability.

Areas covered: The current approaches and novel developments in the field of age-appropriate drug delivery for pediatric patients are critically discussed including patient-centric formulations, administration devices and packaging systems.

Expert opinion: Despite the incentives provided by recent regulatory modifications and the efforts of formulation scientists, there is still a need for implementation of pharmaceutical technologies that enable the manufacture of licensed age-appropriate formulations. Harmonization of endeavors from regulators, industry and academia by sharing learning associated with data obtained from pediatric investigation plans, product development pathways and scientific projects would be the way forward to speed up bench-to-market age appropriate formulation development. A collaborative approach will benefit not only pediatrics, but other patient populations such as geriatrics would also benefit from an accelerated patient-centric approach to drug delivery.

Download
Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms
Felipe L Lopez, Terry B Ernest, Catherine Tuleu & Mine Orlu Gul (2015) Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms, Expert Opinion on Drug Delivery, 12:11, 1727-1740, DOI: 10.1517/17425247.2015.1060218
To link to this article: http://dx.doi.org/10.1517/17425247.2015.1060218
Formulation approaches to pediatric oral
Adobe Acrobat Document 1.4 MB

Write a comment

Comments: 0